Aberrant FHIT transcripts in human colorectal cancers.

Area of Science:

• Molecular Biology
• Cancer Genetics
• Genomics

Background:

• The FHIT gene, located at chromosome 3p14.2 within the FRA3B fragile region, is frequently altered in various human cancers.
• Understanding FHIT gene alterations is crucial for investigating its role in colorectal cancer development.

Purpose of the Study:

• To investigate the expression and alterations of the FHIT gene in colorectal cancer.
• To analyze the impact of FHIT gene overexpression on cell cycle progression.

Main Methods:

• Reverse transcription-polymerase chain reaction (RT-PCR) was used to examine FHIT gene expression in 20 colorectal cancer samples.
• Aberrant transcripts were cloned and sequenced to identify splicing errors.
• FHIT gene overexpression was induced in normal rat kidney cells (NRK-52E) to assess cell cycle effects.

Main Results:

• RT-PCR revealed abnormal FHIT transcripts in 7 out of 25 colorectal cancer patients, with 16 aberrant transcripts identified.
• Sequence analysis indicated splicing errors, including exon deletions and the presence of intron 5 sequences.
• Overexpression of FHIT in NRK-52E cells did not significantly alter cell proliferation or cell cycle distribution.

Conclusions:

• Alternative splicing, including exon skipping and intron retention, frequently inactivates the FHIT gene in colorectal cancer.
• While FHIT alterations are common, they may not be directly linked to carcinogenicity through cell cycle disruption.
• FHIT gene inactivation via splicing errors is a significant finding in colorectal cancer pathogenesis.